Differential effects of ellagic acid on non-alcoholic fatty liver disease in mice: grouped by urolithin A-producing capacity

< 0.05). This study provided new insights into EA's anti-NAFLD effectiveness and suggested that the response capacity of the gut microbiota to EA greatly determined the performance of EA in alleviating the development of NAFLD.